VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
3581
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
643
Interactions with Platform & by Email
PARTICIPANTS
107
Unique # Participated
VALIDATIONS
48
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
SEP 2020
TABLES
159
PAGES
235
EDITION
7
PRICE
USD $4950
China Has Risen Into An Economic Powerhouse.
Find Out How You Can Leverage This Opportunity!
Amid the COVID-19 crisis, the global market for Cell Viability Assays estimated at US$2.9 Billion in the year 2020, is projected to reach a revised size of US$4.7 Billion by 2027, growing at aCAGR of 7% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6% CAGR for the next 7-year period.
The Cell Viability Assays market in the U.S. is estimated at US$864.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$821.8 Million by the year 2027 trailing a CAGR of 6.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.6% and 5.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.We bring years of research experience to this 7th edition of our report. The 235-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Abcam PLC; Becton, Dickinson and Company; Bio-Rad Laboratories, Inc.; BioTek Instruments, Inc.; Biotium, Inc.; Creative Bioarray; Danaher Corporation; GE Healthcare; Merck KgaA; PerkinElmer, Inc.; Promega Corporation; Thermo Fisher Scientific, Inc.
» Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, Other Applications) » End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital and Diagnostic Laboratories, Other End-Uses) » Product Type (Consumables, Instruments)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Cell Viability Assays Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Cell Viability Assays Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 |
| Cell Viability Assays Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019 |
| Cell Viability Assays Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 |
| Consumables (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Consumables (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 |
| Consumables (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Instruments (Product Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 |
| Instruments (Product Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019 |
| Instruments (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 |
| Basic Research (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027 |
| Basic Research (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019 |
| Basic Research (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 |
| Stem Cell Research (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027 |
| Stem Cell Research (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 |
| Stem Cell Research (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027 |
| Drug Discovery & Development (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027 |
| Drug Discovery & Development (Application) Global Historic Analysis in US$ Million by Region/Country: 2012-2019 |
| Drug Discovery & Development (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Clinical & Diagnostic Applications (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027 |
| Clinical & Diagnostic Applications (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019 |
| Clinical & Diagnostic Applications (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027 |
| Other Applications (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027 |
| Other Applications (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 |
| Other Applications (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Academic & Research Institutes (End-Use) Worldwide Sales in US$ Million by Region/Country: 2020-2027 |
| Academic & Research Institutes (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019 |
| Academic & Research Institutes (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027 |
| Pharmaceutical & Biotechnology Companies (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027 |
| Pharmaceutical & Biotechnology Companies (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019 |
| Pharmaceutical & Biotechnology Companies (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 |
| Hospital & Diagnostic Laboratories (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027 |
| Hospital & Diagnostic Laboratories (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 |
| Hospital & Diagnostic Laboratories (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027 |
| Other End-Uses (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027 |
| Other End-Uses (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2012-2019 |
| Other End-Uses (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Cell Viability Assays Market Share (in %) by Company: 2019 & 2025 |
| United States Cell Viability Assays Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027 |
| Cell Viability Assays Market in the United States by Product Type: A Historic Review in US$ Million for 2012-2019 |
| United States Cell Viability Assays Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027 |
| United States Cell Viability Assays Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 |
| Cell Viability Assays Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019 |
| Cell Viability Assays Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027 |
| United States Cell Viability Assays Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027 |
| Cell Viability Assays Historic Demand Patterns in the United States by End-Use in US$ Million for 2012-2019 |
| Cell Viability Assays Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027 |
| CANADA |
| Canadian Cell Viability Assays Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027 |
| Canadian Cell Viability Assays Historic Market Review by Product Type in US$ Million: 2012-2019 |
| Cell Viability Assays Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027 |
| Canadian Cell Viability Assays Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 |
| Cell Viability Assays Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 |
| Canadian Cell Viability Assays Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| Canadian Cell Viability Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027 |
| Cell Viability Assays Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019 |
| Canadian Cell Viability Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| JAPAN |
| Japanese Market for Cell Viability Assays: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027 |
| Cell Viability Assays Market in Japan: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019 |
| Japanese Cell Viability Assays Market Share Analysis by Product Type: 2012 VS 2020 VS 2027 |
| Japanese Demand Estimates and Forecasts for Cell Viability Assays in US$ Million by Application: 2020 to 2027 |
| Japanese Cell Viability Assays Market in US$ Million by Application: 2012-2019 |
| Cell Viability Assays Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027 |
| Japanese Demand Estimates and Forecasts for Cell Viability Assays in US$ Million by End-Use: 2020 to 2027 |
| Japanese Cell Viability Assays Market in US$ Million by End-Use: 2012-2019 |
| Cell Viability Assays Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027 |
| CHINA |
| Chinese Cell Viability Assays Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027 |
| Cell Viability Assays Historic Market Analysis in China in US$ Million by Product Type: 2012-2019 |
| Chinese Cell Viability Assays Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Chinese Demand for Cell Viability Assays in US$ Million by Application: 2020 to 2027 |
| Cell Viability Assays Market Review in China in US$ Million by Application: 2012-2019 |
| Chinese Cell Viability Assays Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| Chinese Demand for Cell Viability Assays in US$ Million by End-Use: 2020 to 2027 |
| Cell Viability Assays Market Review in China in US$ Million by End-Use: 2012-2019 |
| Chinese Cell Viability Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 |
| EUROPE |
| Market Facts & Figures |
| European Cell Viability Assays Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Cell Viability Assays Market Demand Scenario in US$ Million by Region/Country: 2020-2027 |
| Cell Viability Assays Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019 |
| European Cell Viability Assays Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 |
| European Cell Viability Assays Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027 |
| Cell Viability Assays Market in Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019 |
| European Cell Viability Assays Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027 |
| European Cell Viability Assays Addressable Market Opportunity in US$ Million by Application: 2020-2027 |
| Cell Viability Assays Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 |
| European Cell Viability Assays Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| European Cell Viability Assays Addressable Market Opportunity in US$ Million by End-Use: 2020-2027 |
| Cell Viability Assays Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019 |
| European Cell Viability Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| FRANCE |
| Cell Viability Assays Market in France by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| French Cell Viability Assays Historic Market Scenario in US$ Million by Product Type: 2012-2019 |
| French Cell Viability Assays Market Share Analysis by Product Type: 2012 VS 2020 VS 2027 |
| Cell Viability Assays Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027 |
| French Cell Viability Assays Historic Market Review in US$ Million by Application: 2012-2019 |
| French Cell Viability Assays Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 |
| Cell Viability Assays Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027 |
| French Cell Viability Assays Historic Market Review in US$ Million by End-Use: 2012-2019 |
| French Cell Viability Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 |
| GERMANY |
| Cell Viability Assays Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027 |
| German Cell Viability Assays Historic Market Analysis in US$ Million by Product Type: 2012-2019 |
| German Cell Viability Assays Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027 |
| Cell Viability Assays Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 |
| German Cell Viability Assays Market in Retrospect in US$ Million by Application: 2012-2019 |
| Cell Viability Assays Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027 |
| Cell Viability Assays Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027 |
| German Cell Viability Assays Market in Retrospect in US$ Million by End-Use: 2012-2019 |
| Cell Viability Assays Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027 |
| ITALY |
| Italian Cell Viability Assays Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027 |
| Cell Viability Assays Historic Market Analysis in Italy in US$ Million by Product Type: 2012-2019 |
| Italian Cell Viability Assays Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Italian Demand for Cell Viability Assays in US$ Million by Application: 2020 to 2027 |
| Cell Viability Assays Market Review in Italy in US$ Million by Application: 2012-2019 |
| Italian Cell Viability Assays Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| Italian Demand for Cell Viability Assays in US$ Million by End-Use: 2020 to 2027 |
| Cell Viability Assays Market Review in Italy in US$ Million by End-Use: 2012-2019 |
| Italian Cell Viability Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 |
| UNITED KINGDOM |
| United Kingdom Market for Cell Viability Assays: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027 |
| Cell Viability Assays Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019 |
| United Kingdom Cell Viability Assays Market Share Analysis by Product Type: 2012 VS 2020 VS 2027 |
| United Kingdom Demand Estimates and Forecasts for Cell Viability Assays in US$ Million by Application: 2020 to 2027 |
| United Kingdom Cell Viability Assays Market in US$ Million by Application: 2012-2019 |
| Cell Viability Assays Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027 |
| United Kingdom Demand Estimates and Forecasts for Cell Viability Assays in US$ Million by End-Use: 2020 to 2027 |
| United Kingdom Cell Viability Assays Market in US$ Million by End-Use: 2012-2019 |
| Cell Viability Assays Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027 |
| REST OF EUROPE |
| Rest of Europe Cell Viability Assays Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027 |
| Cell Viability Assays Market in Rest of Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019 |
| Rest of Europe Cell Viability Assays Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027 |
| Rest of Europe Cell Viability Assays Addressable Market Opportunity in US$ Million by Application: 2020-2027 |
| Cell Viability Assays Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 |
| Rest of Europe Cell Viability Assays Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| Rest of Europe Cell Viability Assays Addressable Market Opportunity in US$ Million by End-Use: 2020-2027 |
| Cell Viability Assays Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019 |
| Rest of Europe Cell Viability Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| ASIA-PACIFIC |
| Cell Viability Assays Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Asia-Pacific Cell Viability Assays Historic Market Scenario in US$ Million by Product Type: 2012-2019 |
| Asia-Pacific Cell Viability Assays Market Share Analysis by Product Type: 2012 VS 2020 VS 2027 |
| Cell Viability Assays Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027 |
| Asia-Pacific Cell Viability Assays Historic Market Review in US$ Million by Application: 2012-2019 |
| Asia-Pacific Cell Viability Assays Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 |
| Cell Viability Assays Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027 |
| Asia-Pacific Cell Viability Assays Historic Market Review in US$ Million by End-Use: 2012-2019 |
| Asia-Pacific Cell Viability Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 |
| REST OF WORLD |
| Rest of World Cell Viability Assays Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027 |
| Rest of World Cell Viability Assays Historic Market Review by Product Type in US$ Million: 2012-2019 |
| Cell Viability Assays Market in Rest of World: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027 |
| Rest of World Cell Viability Assays Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 |
| Cell Viability Assays Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 |
| Rest of World Cell Viability Assays Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| Rest of World Cell Viability Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027 |
| Cell Viability Assays Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019 |
| Rest of World Cell Viability Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| IV. COMPETITION |
| Total Companies Profiled : 46 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com